{"filing":{"accession_number":"0001731122-26-001012","cik":"0001553788","ticker":"SBEVW","company_name":"SPLASH BEVERAGE GROUP, INC.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-07-31","primary_document":"e7825_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226001012/e7825_8-k.htm"},"events":[{"id":23656,"run_id":21392,"accession_number":"0001731122-26-001012","anchor_item_number":"1.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"Splash Beverage entered into a Development and Collaboration Agreement with Lupvindol Biosciences on July 31, 2026, to develop a cannabinoid-based veterinary drug (CannEpil®) through FDA regulatory approval, with milestone payments totaling up to $940,000 plus ongoing royalties or equity. This is a material strategic partnership involving significant capital commitment and regulatory development, but does not constitute a traditional M\u0026A transaction, debt issuance, or other specifically-named event type—it is a material operational/strategic collaboration agreement best classified as operational_other.","company_name":"SPLASH BEVERAGE GROUP, INC.","ticker":"SBEVW","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":23954,"accession_number":"0001731122-26-001012","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Splash Beverage entered into a Development and Collaboration Agreement with Lupvindol Biosciences on July 31, 2026, to develop a cannabinoid-based veterinary drug (CannEpil®) through FDA regulatory approval, with milestone payments totaling up to $940,000 plus ongoing royalties or equity. This is a material strategic partnership involving significant capital commitment and regulatory development, but does not constitute a traditional M\u0026A transaction, debt issuance, or other specifically-named event type—it is a material operational/strategic collaboration agreement best classified as operational_other.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:19:02.222400+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23954,"accession_number":"0001731122-26-001012","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Splash Beverage entered into a Development and Collaboration Agreement with Lupvindol Biosciences on July 31, 2026, to develop a cannabinoid-based veterinary drug (CannEpil®) through FDA regulatory approval, with milestone payments totaling up to $940,000 plus ongoing royalties or equity. This is a material strategic partnership involving significant capital commitment and regulatory development, but does not constitute a traditional M\u0026A transaction, debt issuance, or other specifically-named event type—it is a material operational/strategic collaboration agreement best classified as operational_other.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:19:02.222400+00:00","company_name":"SPLASH BEVERAGE GROUP, INC.","ticker":"SBEVW","filing_date":"2026-08-04"}]}